In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy

Tanya L. Applegate, Donald J. Birkett, Glen J. Mcintyre, Angel B. Jaramillo, Geoff Symonds, John M. Murray

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)
26 Downloads (Pure)

Fingerprint

Dive into the research topics of 'In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science